[Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver].
OBJECTIVE
To observe therapeutic effect of acupoint-injection of Kaixilai on non-alcoholic fatty liver.


METHODS
One hundred cases of non-alcoholic fatty liver were randomly divided into a test group and a control group, 50 cases in each group. The test group were treated with injection of 2 mL Kaixilai injection into Zusanli (ST 36), thrice each week, for 3 months; and the control group were treated with intravenous drip of 200 mL Kaixilai injection, once each day, for 3 months. Changes of triglyceride (TG), total cholesterol (TC), malondialhyde (MDA), superoxide dismutase (SOD), glutamic-oxaloacetic transaminase (AST), glutamic-pyruvic transaminase (ALT), and clinical symptoms were observed in the two groups.


RESULTS
There were significant differences before and after treatment in the symptoms, TG, TC, MDA, SOD, AST and ALT in the two groups (P<0.05), with no significant difference between the two groups (P>0.05).


CONCLUSIONS
Acupoint-injection of Kaixilai is an effective therapy for non-alcoholic fatty liver, with convenience, economic and no adverse effect.
Jin
Jian-jun
JJ
Clinical Medical College, Gansu College of TCM, Lanzhou 730000, China. jinjianjun838@sina.com
Xu
Ya-li
YL
Zheng
Yu
Y
D015669:Acupuncture Points; D000818:Animals; D005235:Fatty Liver, Alcoholic; D006801:Humans; D008099:Liver; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase
D013482:Superoxide Dismutase